Type I IFNs differentially modulate IL-12p70 production by human dendritic cells depending on the maturation status of the cells and counteract IFN-γ-mediated signaling
- 1 June 2003
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 107 (3) , 170-177
- https://doi.org/10.1016/s1521-6616(03)00060-3
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- IFN‐α enhances CD40 ligand‐mediated activation of immature monocyte‐derived dendritic cellsInternational Immunology, 2002
- Interferon β in multiple sclerosis: is IL-12 suppression the key?Immunology Today, 2000
- Two Roads Diverged: Interferon α/β– and Interleukin 12–mediated Pathways in Promoting T Cell Interferon γ Responses during Viral InfectionThe Journal of Experimental Medicine, 1999
- Management of Multiple SclerosisNew England Journal of Medicine, 1997
- Selective Expression of an Interleukin-12 Receptor Component by Human T Helper 1 CellsThe Journal of Experimental Medicine, 1997
- Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products.The Journal of Experimental Medicine, 1995
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- EXACERBATIONS OF MULTIPLE SCLEROSIS IN PATIENTS TREATED WITH GAMMA INTERFERONPublished by Elsevier ,1987
- Interferon α/β selectively antagonises down-regulation of mannosyl-fucosyl receptors on activated macrophages by interferon γBiochemical and Biophysical Research Communications, 1986
- Contrasting effect of alpha/beta- and gamma-interferons on expression of macrophage Ia antigens.The Journal of Experimental Medicine, 1986